50 employees
Cynapsus is a pharmaceutical company that focuses on developing a non-injectable drug for Parkinson’s disease.
2004
$16M
from 3 investors over 3 rounds
Cynapsus Therapeutics raised $16M on March 31, 2015
Investors: OrbiMed Advisors, Venrock and Aisling Capital